Digital Health Global
DECEMBER 5, 2023
Alzheimer’s disease will affect 13 million Americans by 2050 , up from 6 million in 2023. Also, the financial burden in the United States is tremendous, expected to exceed $345 billion in 2023 and surpass $1 trillion by 2050.
Redox
SEPTEMBER 26, 2023
Top stories CMS creates all-payer model for states CMS is offering an all-payer funding opportunity of up to $12M for eight states to improve population health. The post Vital Lines September 2023 appeared first on Redox. Learn more Was this forwarded to you?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
FEBRUARY 19, 2024
Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.
Digital Health Global
JANUARY 4, 2024
Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Nitin Ohri at Montefiore Medical Center in collaboration with Koneksa, presented at 2023 ASCO Quality Care.
Digital Health Global
APRIL 5, 2024
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. growth between 2023 to 2024. Overall R&D expenditure totals about $276.81 billion, with a slow 2.5%
Digital Health Global
JANUARY 9, 2024
The investment adds to a growing list of prominent digital health investors in Europe and the United States, including Nina Capital and Young Sohn, a co-founder of Veeva Systems. The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “
Digital Health Global
APRIL 16, 2024
Medable, which ranked in the top 8% of software companies on the 2023 Inc. Medable, which ranked in the top 8% of software companies on the 2023 Inc. 5000 in 2023. “Total Consent improves the experience for all participants plus it’s easy for sites to deploy even in large, multidimensional trials like with USRC.
Expert insights. Personalized for you.
88 
Let's personalize your content